133 related articles for article (PubMed ID: 3403672)
1. Inoculation of BALB/c mice against Leishmania major infection with Leishmania-derived antigens isolated by gel filtration.
Ogunkolade BW; Monjour L; Vouldoukis I; Rhodes-Feuillette A; Frommel D
J Chromatogr; 1988 May; 440():459-65. PubMed ID: 3403672
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.
Frommel D; Ogunkolade BW; Vouldoukis I; Monjour L
Infect Immun; 1988 Apr; 56(4):843-8. PubMed ID: 3346074
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies against defined Leishmania antigens protect mice against infection by different species of Leishmania].
Monjour L; Berneman A; Vouldoukis I; Domurado M; Guillemin MC; Chopin C; Alfred C; Roseto A
C R Acad Sci III; 1985; 300(9):395-8. PubMed ID: 3922585
[TBL] [Abstract][Full Text] [Related]
4. Immunoprophylaxis against Leishmania infections with a semi-purified antigen.
Monjour L; Ogunkolade BW; Vouldoukis I; Roseto A; Berneman A; Frommel D
Trans R Soc Trop Med Hyg; 1986; 80(6):1013. PubMed ID: 3603634
[No Abstract] [Full Text] [Related]
5. Mimetic membrane system to carry multiple antigenic proteins from Leishmania amazonensis.
Santos FR; Ferraz DB; Daghastanli KR; Ramalho-Pinto FJ; Ciancaglini P
J Membr Biol; 2006 Apr; 210(3):173-81. PubMed ID: 16909340
[TBL] [Abstract][Full Text] [Related]
6. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
[TBL] [Abstract][Full Text] [Related]
7. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
8. [An immunologic method of producing antigens for the treatment and prevention of leishmaniasis].
Vouldoukis I; Monjour L
C R Acad Sci III; 1989; 308(5):129-34. PubMed ID: 2493318
[TBL] [Abstract][Full Text] [Related]
9. Leishmanin skin test in guinea pig with a single purified protein of Leishmania major.
Khabiri AR; Bagheri F; Alimohammadian MH; Assmar M; Nadaf SR
Exp Parasitol; 2005 Dec; 111(4):239-43. PubMed ID: 16212955
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].
Monjour L; Ogunkolade W; Pointet P; Vouldoukis I
C R Acad Sci III; 1985; 301(18):803-6. PubMed ID: 3936605
[TBL] [Abstract][Full Text] [Related]
12. Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen.
Kweider M; Lemesre JL; Santoro F; Kusnierz JP; Sadigursky M; Capron A
Parasite Immunol; 1989 May; 11(3):197-209. PubMed ID: 2771426
[TBL] [Abstract][Full Text] [Related]
13. Lipid and lipopolysaccharide-like antigens of Leishmania promastigotes.
Slutzky GM; Londner MV; Greenblatt CL
J Protozool; 1985 May; 32(2):347-52. PubMed ID: 4009512
[TBL] [Abstract][Full Text] [Related]
14. A common major surface antigen on amastigotes and promastigotes of Leishmania species.
Colomer-Gould V; Glvao Quintao L; Keithly J; Nogueira N
J Exp Med; 1985 Sep; 162(3):902-16. PubMed ID: 4031788
[TBL] [Abstract][Full Text] [Related]
15. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
16. Chitosan Nanoparticles Loaded with Whole and Soluble Leishmania Antigens, and Evaluation of Their Immunogenecity in a Mouse Model of Leishmaniasis.
Hojatizade M; Soleymani M; Tafaghodi M; Badiee A; Chavoshian O; Jaafari MR
Iran J Immunol; 2018 Dec; 15(4):281-293. PubMed ID: 30593742
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic proteins of Leishmania major during mouse infection.
Nguyen TV; Mauel J; Etges RJ; Bouvier J; Bordier C
Parasite Immunol; 1984 May; 6(3):265-73. PubMed ID: 6739122
[TBL] [Abstract][Full Text] [Related]
18. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.
Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G
Arch Dermatol Res; 2012 Jan; 304(1):47-55. PubMed ID: 21882046
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
Alexander J; Kaye PM
Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
